Study finds anti-nausea med OK for moms-to-be and fetuses
Attention nauseous pregnant women: More relief may be on the way! A new study says an anti-nausea drug that is widely used but largely untested in pregnant women may be used in expectant women without causing harm to a fetus, The Associated Press reports.
Israeli and Canadian researchers report in the New England Journal of Medicine that they found no increase in deaths or birth defects among the babies of women given metoclopramide during the first trimester of pregnancy. They also said that using metoclopramide did not raise a woman's risk of giving birth to a low-weight baby or to a baby with a low Apgar score, the widely used measure of the health of a child immediately after birth.
Morning sickness is a trademark of early pregnancy for most women. But despite its pervasiveness, there's still no one-size-fits-all treatment for that pesky nausea, especially when some women aren't open to using medication. Metoclopramide is not approved by the Food and Drug Administration for use in expectant U.S. women, but it is dispensed widely in Europe and other countries to treat morning sickness. More U.S. studies are in the works, however. Currently, Compazine, Phenergan and Zofran are the most frequently prescribed in the U.S. for morning sickness.
As many as 80 percent of moms-to-be suffer morning sickness in the first trimester. For the lucky ones, it can be controlled with non-medication options. If you're sick of being sick, these remedies (both mainstream and alternative, should help you feel better. Some experts even say exercise can help ease your nausea!
If you want to see how another mommy-to-be is faring with this condition, follow Fit Pregnancy.com's Managing Editor Dana Rousmaniere as she deals with her morning sickness—in her third pregnancy!
And of course, there's the old wives' tale about nausea and gender. Remember, take it with a grain of salt!
Maria Vega is Fit Pregnancy magazine's copy editor.